دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Subscription Information
doi : 10.1016/S0085-2538(23)00569-0
Volume 104, Issue 4, October 2023, Page A2
Table of Contents
doi : 10.1016/S0085-2538(23)00570-7
Volume 104, Issue 4, October 2023, Pages A3-A6
Using causal directed acyclic graphs (DAGs) to select patient-important outcomes in transplantation trials—interventions to treat polyomavirus infection as an example
Yue Wu1 , Michael Dymock 2 , Ryan Gately 3 , Julie A. Marsh2,4 , Carmel Hawley 3 , Germaine Wong 1,5 and Thomas L. Snelling
doi : 10.1016/j.kint.2023.07.013
Volume 104, Issue 4, October 2023, Pages 628-633
Polycystin-2, mechanosensing, and left-right asymmetry in autosomal dominant polycystic kidney disease
Zhiyong Chen 1 and Iain A. Drummond 2
doi : 10.1016/j.kint.2023.03.023
Volume 104, Issue 4, October 2023, Pages 638-640
Leave NOSTONE unturned: are thiazides useless in preventing kidney stone recurrence?
Franc¸ois Brazier 1,2 , Nicolas Cornie`re 1,2 and Dominique Eladari 1,
doi : 10.1016/j.kint.2023.06.030
Volume 104, Issue 4, October 2023, Pages 640-643
Linking donor-specific antibody generation with natural killer cells in antibody-mediated kidney graft rejection
Griffith B. Perkins 1,2,3 and Robert L. Fairchild
doi : 10.1016/j.kint.2023.07.014
Volume 104, Issue 4, October 2023, Pages 644-646
Suppressing succinate accumulation during ischemia protects the kidney from IRI
Nobuaki Nishima 1 and Shinji Tanaka
doi : 10.1016/j.kint.2023.07.011
Volume 104, Issue 4, October 2023, Pages 646-649
Autoregulatory mission impossible: when afferent arterioles lose contractility
Jing Wu 1,2 and Thu H. Le
doi : 10.1016/j.kint.2023.07.019
Volume 104, Issue 4, October 2023, Pages 649-651
A first small step toward personalized immunosuppression
Klemens Budde 1 and Lionel Rostaing
doi : 10.1016/j.kint.2023.06.036
Volume 104, Issue 4, October 2023, Pages 652-654
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Elaine Ku 1,2,3 , Lucia Del Vecchio 4 , Kai-Uwe Eckardt 5 , Volker H. Haase 6,7,8 , Kirsten L. Johansen 9,10 , Masaomi Nangaku 11 , Navdeep Tangri 12,13 , Sushrut S. Waikar 14 , Andrzej Wie?cek 15 , Michael Cheung 16 , Michel Jadoul 17 , Wolfgang C. Winkelmayer18 , and David C. Wheeler 19 ; for Conference Participants 20
doi : 10.1016/j.kint.2023.05.009
Volume 104, Issue 4, October 2023, Pages 655-680
Models of care to address disparities in kidney health outcomes for First Nations people
Samantha Bateman1,2,3 , Michael Riceman 1,2 , Kelli Owen 2,3,4 , Odette Pearson 2,5 , Rhanee Lester 2,4 , Nari Sinclair 2,4 , Stephen McDonald 1,2,3 , Martin Howell 6,7 , David J. Tunnicliffe6,7 and Shilpanjali Jesudason
doi : 10.1016/j.kint.2023.06.026
Volume 104, Issue 4, October 2023, Pages 681-689
Novel mechanisms of salt-sensitive hypertension
Liffert Vogt 1 , Francine Z. Marques 2,3 , Toshiro Fujita 4 , Ewout J. Hoorn 5 and A.H. Jan Danser
doi : 10.1016/j.kint.2023.06.035
Volume 104, Issue 4, October 2023, Pages 690-697
Vitamin D supplementation in people with chronic kidney disease
Marc G. Vervloet 1,2 , Simon Hsu 3 and Ian H. de Boer
doi : 10.1016/j.kint.2023.07.010
Volume 104, Issue 4, October 2023, Pages 698-706
Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody–mediated rejection showing a new link between adaptive and innate humoral allo-immunity
Elodie Bailly 1,2 , Camila Macedo 1 , Jason Ossart 1 , Kevin Louis 2 , Xinyan Gu 1 , Bala Ramaswami 1 , Carol Bentlejewski 1 , Adriana Zeevi 1 , Parmjeet Randhawa 1 , Carmen Lefaucheur 2 and Diana Metes
doi : 10.1016/j.kint.2023.04.024
Volume 104, Issue 4, October 2023, Pages 707-723
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion
Chang Joo Oh 1,17 , Min-Ji Kim 2,17 , Ji-Min Lee 3,17 , Dong Hun Kim 4 , Il-Young Kim 5,6 , Sanghee Park 7 , Yeongmin Kim 8 , Kyung-Bok Lee 9 , Sang-Hee Lee 9 , Chae Won Lim 10 , Myeongjin Kim 10 , Jung-Yi Lee 1 , Haushabhau S. Pagire 11 , Suvarna H. Pagire 11 , Myung Ae Bae 12 , Dipanjan Chanda 1 , Themis Thoudam1 , Ah Reum Khang 13 , Robert A. Harris 14 , Jin Hee Ahn 11,18 , Jae-Han Jeon 1,15,18 and In-Kyu Lee 1,16
doi : 10.1016/j.kint.2023.06.022
Volume 104, Issue 4, October 2023, Pages 724-739
Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease
Wenguang Feng 1 , Zhengrong Guan 1 , Wei-Zhong Ying1 , Dongqi Xing 1 , Kai Er Ying 1 and Paul W. Sanders 1,
doi : 10.1016/j.kint.2023.06.031
Volume 104, Issue 4, October 2023, Pages 740-753
Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome
Cecilie K. Skeby 1,6 , Sandra Hummelgaard 1,6 , Camilla Gustafsen 1,2 , Federica Petrillo 1 , Kathrine P. Frederiksen 1 , Ditte Olsen 1,2 , Tilde Kristensen 3,4 , Per Ivarsen 4,5 , Peder Madsen 1,2 , Erik I. Christensen 1 , Rikke Nielsen 1 , Henrik Birn 1,4,5 , Simon Glerup 1,2 and Kathrin Weyer
doi : 10.1016/j.kint.2023.06.024
Volume 104, Issue 4, October 2023, Pages 754-768
Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis
Chaoyi Yuan 1,10 , Guannan Jin 2,10 , Pengcheng Li 1,10 , Wei Wang 1,10 , Chang Ge3 , Yonglong Pan 1 , Qiaofeng Zhang 1 , Jie Mo 1 , Dong Kuang 4 , Liu Liu 5 , Xuewu Zhang 1 , Huifang Liang 1 , Wanguang Zhang 1 , Xi Tang 6 , Zifu Li7 , Jihong Liu 8 , Gang Xu 5 , Xiaoping Chen 1,9 , Ze-yang Ding 1 and Bixiang Zhang
doi : 10.1016/j.kint.2023.07.006
Volume 104, Issue 4, October 2023, Pages 769-786
Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease
Farah Lizotte 1 , Marina Rousseau 1 , Benoit Denhez 1 , Dominique Le´vesque 2 , Andre´anne Guay 1 , HongBo Liu 3,4,5,6 , Julie Moreau 1 , Sarah Higgins 7 , Robert Sabbagh 8 , Katalin Susztak3,4,5,6 , Franc¸ois-Michel Boisvert 2 , Anne Marie Coˆ te´ 1,7 and Pedro Geraldes 1,9
doi : 10.1016/j.kint.2023.06.038
Volume 104, Issue 4, October 2023, Pages 787-802
Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing
Nicolas Delaleu 1,2,15 , Hans-Peter Marti 2,3,15 , Philipp Strauss 2 , Miroslav Sekulic 4 , Tarig Osman 2 , Camilla T?ndel 2,5 , Rannveig Skrunes 2,3 , Sabine Leh 2,6 , Einar Svarstad 2,3 , Albina Nowak 7 , Ariana Gaspert 8 , Elena Rusu 9,10 , Ivo Kwee 11 , Andrea Rinaldi 12 , Arnar Flatberg 13,14 and Oystein Eikrem
doi : 10.1016/j.kint.2023.06.029
Volume 104, Issue 4, October 2023, Pages 803-819
A cohort study found a high risk of end-stage kidney disease associated with acromegaly
Sangmo Hong 1,5 , Kyung-Soo Kim 2,5 , Kyungdo Han 3 and Cheol-Young Park
doi : 10.1016/j.kint.2023.06.037
Volume 104, Issue 4, October 2023, Pages 820-827
Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes
Taha Sen1,12 , Wenjun Ju 2,3,12 , Viji Nair 2 , Patricia Ladd 4 , Rajasree Menon 2,3 , Edgar A. Otto 2 , Laura Pyle 5,6 , Tim Vigers5,6 , Robert G. Nelson 7 , Clare Arnott 8,9 , Bruce Neal 8 , Michael K. Hansen 10 , Matthias Kretzler 2,3,13 , Petter Bjornstad 6,11,13 and Hiddo J.L. Heerspink
doi : 10.1016/j.kint.2023.07.007
Volume 104, Issue 4, October 2023, Pages 828-839
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
Nuria Lloberas 1 , Josep M. Grinyo´ 2 , Helena Colom 3 , Anna Vidal-Alabro´ 1 , Pere Fontova 1 , Raul Rigo-Bonnin 4 , Ariadna Padro´ 4 , Oriol Bestard 1 , Edoardo Melilli 1 , Nuria Montero 1 , Ana Coloma1 , Anna Manonelles1 , Maria Meneghini 1 , Alex Fava` 1 , Joan Torras 1 and Josep M. Cruzado
doi : 10.1016/j.kint.2023.06.021
Volume 104, Issue 4, October 2023, Pages 840-850
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Ana Huerta 1,2,14 , Emi Arjona 3,4,14 , Jose Portoles 1,2 , Paula Lopez-Sanchez 1 , Teresa Cavero 5 , Jeanette Fernandez-Cusicanqui 6 , Miquel Blasco 7 , Virginia Cabello 8 , Natividad Calvo 9 , Montserrat Diaz 10 , Maria Herrero-Gon? i 11 , Mireia Aguirre 11 , Sandra El?´as 12 , Maria Paz Alcaide 8 , Natalia Ramos 13 , Joana Sellares 13 and Santiago Rodr?´guez de Co´ rdoba
doi : 10.1016/j.kint.2023.07.020
Volume 104, Issue 4, October 2023, Pages 851-855
The conclusion that myeloperoxidase inhibition is not protective against anti-neutrophil cytoplasmic autoantibody–associated vasculitis is premature
Tomoki Taniguchi1 , Ryosuke Hiwa 1 and Akio Morinobu
doi : 10.1016/j.kint.2023.07.008
Volume 104, Issue 4, October 2023, Page 856
The authors reply
Fernanda Florez-Barros 1 , Siobhan Bearder 1 , Bengt Kull 2 , Adrian Freeman 2 , Attila Mo´ csai 3 and Michael G. Robson
doi : 10.1016/j.kint.2023.07.009
Volume 104, Issue 4, October 2023, Pages 856-857
Prioritizing water stewardship in kidney replacement therapies
Caroline E. Stigant 1 , Katherine A. Barraclough 2,3 , Mark Harber 4 , Nigel S. Kanagasundaram 5,6 David S. Goldfarb 7,8 , Charu Malik 9 , Vivekanand Jha10,11,12 and Raymond C. Vanholder
doi : 10.1016/j.kint.2023.07.016
Volume 104, Issue 4, October 2023, Page 857
The authors reply
Mohamed Ben Hmida 1,2 , Tahar Mechichi 3 , Giorgina Barbara Piccoli 4 and Mohamed Ksibi
doi : 10.1016/j.kint.2023.07.015
Volume 104, Issue 4, October 2023, Pages 857-858
Corrigendum to “International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology.� Kidney International, 2023;104:36–45
Masaomi Nangaku 1 , A. Richard Kitching 2,3,4 , Peter Boor 5 , Alessia Fornoni 6,7 , Ju¨ rgen Floege 8 , P. Toby Coates 9,10,11 , Jonathan Himmelfarb 12 , Rachel Lennon 13,14 , Hans-Joachim Anders 15 , Benjamin D. Humphreys 16 , Fergus J. Caskey 17 , Agnes B. Fogo 18 ; and the TRANSFORM group
doi : 10.1016/j.kint.2023.08.001
Volume 104, Issue 4, October 2023, Page 859
Cryofibrinogen-associated membranoproliferative glomerulonephritis
Minah Kim 1 , Sung Sun Kim 2 , Hoon-In Choi 3,4 , Hong Sang Choi 3,4 , Eun Hui Bae 3,4 , Seong Kwon Ma 3,4 , Soo Wan Kim 3,4 and Chang Seong Kim
doi : 10.1016/j.kint.2023.05.004
Volume 104, Issue 4, October 2023, Page 860
Intussusception as a complication of idiopathic nephrotic syndrome
Fanny Dreant 1 , Benedicte Sautenet 1,2 , Christelle Barbet 1 and Jean-Michel Halimi 1,
doi : 10.1016/j.kint.2023.04.032
Volume 104, Issue 4, October 2023, Page 861
The Case | Acute kidney injury following infective endocarditis
Cyril Mousseaux 1,2,3 , Ellie Tang 2,4 , Maxime Tristant 1 , Yosu Luque 1,2,3 , Vincent Frochot 4 , Laurent Mesnard 1,2,3 , Dominique Bazin 5 , Cédric Rafat 1 , David Buob 2,3,6 and Emmanuel Letavernier
doi : 10.1016/j.kint.2023.06.028
Volume 104, Issue 4, October 2023, Pages 863-864
